Cargando…

Chronic treatment with fluoxetine for more than 6 weeks decreases neurogenesis in the subventricular zone of adult mice

BACKGROUND: Recent studies indicate that chronic treatment with serotonergic antidepressants upregulates adult neurogenesis of the dentate gyrus (DG). In contrast, some studies claimed that there was very little alteration of neurogenesis in the subventricular zone (SVZ) by the antidepressants. Sinc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohira, Koji, Miyakawa, Tsuyoshi
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060120/
https://www.ncbi.nlm.nih.gov/pubmed/21385396
http://dx.doi.org/10.1186/1756-6606-4-10
_version_ 1782200498313494528
author Ohira, Koji
Miyakawa, Tsuyoshi
author_facet Ohira, Koji
Miyakawa, Tsuyoshi
author_sort Ohira, Koji
collection PubMed
description BACKGROUND: Recent studies indicate that chronic treatment with serotonergic antidepressants upregulates adult neurogenesis of the dentate gyrus (DG). In contrast, some studies claimed that there was very little alteration of neurogenesis in the subventricular zone (SVZ) by the antidepressants. Since almost all of those studies treated animals with drugs for 2 to 4 weeks as chronic treatment models of antidepressants, it is possible that antidepressant treatments for longer periods would affect adult neurogenesis in the SVZ. RESULTS: In the present study, we examined the effects of long-term (up to 9 weeks) administration of fluoxetine (FLX), a selective serotonin reuptake inhibitor, on cell proliferation and survival in the DG and the SVZ of adult mice. As reported previously, in the DG of mice treated with FLX for 3, 6, or 9 weeks that were also injected with 5-bromodeoxyuridine (BrdU) in the last 3 days before perfusion, the numbers of Ki67- and BrdU-positive cells, which are cell proliferation markers, were significantly upregulated even at 3 weeks after the onset of the FLX treatments, and these increases were sustained in mice treated with FLX for 9 weeks. On the other hand, in the SVZ, we found a small, insignificant decrease in the numbers of Ki67- and BrdU-positive cells at 3 weeks, followed by highly significant decreases in the numbers of Ki67- and BrdU-positive cells at both 6 and 9 weeks. Furthermore, among olfactory newly generated cells that survived for 3 weeks after BrdU injection, the number of new cells was decreased at 9 weeks of FLX treatment. CONCLUSIONS: These results demonstrate that long-term (more than 6 weeks) treatment with FLX has the opposite effect on neurogenesis in the SVZ than it does in the DG. The results also suggest that the decrease in neurogenesis in the SVZ might be involved in some aspects of the drugs' therapeutic effects on depression. In addition, our findings raise the possibility that some of the side effects of antidepressants might be mediated by decreased adult neurogenesis in the SVZ.
format Text
id pubmed-3060120
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30601202011-03-18 Chronic treatment with fluoxetine for more than 6 weeks decreases neurogenesis in the subventricular zone of adult mice Ohira, Koji Miyakawa, Tsuyoshi Mol Brain Research BACKGROUND: Recent studies indicate that chronic treatment with serotonergic antidepressants upregulates adult neurogenesis of the dentate gyrus (DG). In contrast, some studies claimed that there was very little alteration of neurogenesis in the subventricular zone (SVZ) by the antidepressants. Since almost all of those studies treated animals with drugs for 2 to 4 weeks as chronic treatment models of antidepressants, it is possible that antidepressant treatments for longer periods would affect adult neurogenesis in the SVZ. RESULTS: In the present study, we examined the effects of long-term (up to 9 weeks) administration of fluoxetine (FLX), a selective serotonin reuptake inhibitor, on cell proliferation and survival in the DG and the SVZ of adult mice. As reported previously, in the DG of mice treated with FLX for 3, 6, or 9 weeks that were also injected with 5-bromodeoxyuridine (BrdU) in the last 3 days before perfusion, the numbers of Ki67- and BrdU-positive cells, which are cell proliferation markers, were significantly upregulated even at 3 weeks after the onset of the FLX treatments, and these increases were sustained in mice treated with FLX for 9 weeks. On the other hand, in the SVZ, we found a small, insignificant decrease in the numbers of Ki67- and BrdU-positive cells at 3 weeks, followed by highly significant decreases in the numbers of Ki67- and BrdU-positive cells at both 6 and 9 weeks. Furthermore, among olfactory newly generated cells that survived for 3 weeks after BrdU injection, the number of new cells was decreased at 9 weeks of FLX treatment. CONCLUSIONS: These results demonstrate that long-term (more than 6 weeks) treatment with FLX has the opposite effect on neurogenesis in the SVZ than it does in the DG. The results also suggest that the decrease in neurogenesis in the SVZ might be involved in some aspects of the drugs' therapeutic effects on depression. In addition, our findings raise the possibility that some of the side effects of antidepressants might be mediated by decreased adult neurogenesis in the SVZ. BioMed Central 2011-03-08 /pmc/articles/PMC3060120/ /pubmed/21385396 http://dx.doi.org/10.1186/1756-6606-4-10 Text en Copyright ©2011 Ohira and Miyakawa; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Ohira, Koji
Miyakawa, Tsuyoshi
Chronic treatment with fluoxetine for more than 6 weeks decreases neurogenesis in the subventricular zone of adult mice
title Chronic treatment with fluoxetine for more than 6 weeks decreases neurogenesis in the subventricular zone of adult mice
title_full Chronic treatment with fluoxetine for more than 6 weeks decreases neurogenesis in the subventricular zone of adult mice
title_fullStr Chronic treatment with fluoxetine for more than 6 weeks decreases neurogenesis in the subventricular zone of adult mice
title_full_unstemmed Chronic treatment with fluoxetine for more than 6 weeks decreases neurogenesis in the subventricular zone of adult mice
title_short Chronic treatment with fluoxetine for more than 6 weeks decreases neurogenesis in the subventricular zone of adult mice
title_sort chronic treatment with fluoxetine for more than 6 weeks decreases neurogenesis in the subventricular zone of adult mice
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060120/
https://www.ncbi.nlm.nih.gov/pubmed/21385396
http://dx.doi.org/10.1186/1756-6606-4-10
work_keys_str_mv AT ohirakoji chronictreatmentwithfluoxetineformorethan6weeksdecreasesneurogenesisinthesubventricularzoneofadultmice
AT miyakawatsuyoshi chronictreatmentwithfluoxetineformorethan6weeksdecreasesneurogenesisinthesubventricularzoneofadultmice